Kenvue Shares Drop 2.1% While Deal Calculations Account for 88% of Decline in Tylenol Maker

Kenvue Inc. dropped 2.14% to $18.79 on Monday. Increased online searches for acetaminophen brought renewed attention to its Tylenol brand early Tuesday. However, the main factor behind the stock’s decline was its merger formula.

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

As of November 4, 2025, Kimberly-Clark’s stock is trading around $102 per share, near its 52-week low. The current price reflects a dramatic sell-off that occurred on Monday, Nov 3, when KMB plunged from the high-$110s into the low $100s in a single sessionstockanalysis.com. Specifically, the stock collapsed -14.57% on Nov 3 to close at $102.27stockanalysis.com – an unusually large one-day move for a traditionally stable consumer staples stock. That wipeout followed an already soft October for the shares, which had hovered around $119-$120 in the prior weekchartmill.comchartmill.com.
4 November 2025

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong Buy

NVIDIA

94/100
#2 Strong Buy

Meta Platforms

89/100
#3 Buy

Alphabet

87/100
#4 Buy

Amazon

84/100
#5 Selective Buy

Microsoft

82/100
View full portfolio
Editorial model selection. Not personalised advice.